Effects of restrictive formularies in the ambulatory care setting

American Journal of Managed Care

Volumn 8, Issue 1, 2002, Pages 69-76

  Lexchin, Joel ^a  

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

AMBULATORY CARE; ARTICLE; DRUG COST; DRUG FORMULARY; DRUG INFORMATION; DRUG RESEARCH; DRUG UTILIZATION; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; LONG TERM CARE; MEDICAL LITERATURE; METHODOLOGY; OUTCOMES RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PUBLICATION; SHORT COURSE THERAPY;

AMBULATORY CARE; CANADA; DEVELOPED COUNTRIES; DRUG COSTS; DRUG UTILIZATION; FORMULARIES; HEALTH EXPENDITURES; HEALTH SERVICES RESEARCH; HUMANS; MEDICAID; QUALITY OF HEALTH CARE; TREATMENT OUTCOME; UNITED STATES;

EID: 0036162088     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Pharmaceutical policies in OECD countries: Reconciling social and industrial goals
2. Drug coverage decisions: The role of dollars and values
3. Cost effects of restricting cost-effective therapy
4. Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations?
5. Medicaid drug formulary restrictions
6. Impact of a nationwide limited prescribing list: Preliminary findings
7. Intended and unintended consequences of HMO cost-containment strategies: Results from the managed care outcomes project
8. Formulary limitations and the elderly: Results from the managed care outcomes project
9. 2 antagonist prescriptions
10. Initial impact of a Medicaid prior authorization program for NSAID prescriptions
11. Expanding Medicaid drug formulary coverage: Effects on utilization of related services
12. The effects of an internal analgesic formulary restriction on Medicaid drug expenditures in Wisconsin
13. Impact of an open formulary system on the utilization of medical services
14. Pharmacy-enforced outpatient drug treatment protocols: A case study of Medi-Cal restrictions for cefaclor
15. Drug formulary restrictions as a cost-containment policy in Medicaid programs
16. The social drug lag: An examination of pharmaceutical approval delays in Medicaid formularies
17. Effect of a prior-authorization requirement on the use of non-steroidal antiinflammatory drugs by Medicaid patients
18. The elimination of selected drug products from the Michigan Medicaid formulary: A case study
19. A study of the effects of formulary limitations in Medicaid drug programs
20. Withdrawing payment for nonscientific drug therapy: Intended and unexpected effects of a large-scale natural experiment
21. The limited list in general practice: Implications for the costs and effectiveness of prescribing
22. Elimination of over-the-counter medication coverage in the Oregon Medicaid population: The impact on program costs and drug use
23. A critical analysis of studies of state drug reimbursement policies: Research in need of discipline
24. HMO formularies and care costs
25. Drug formularies provide a path to best care
26. Prescription charges, the demand for prescriptions and morbidity
27. The effect of patient charges on the utilisation of prescription benefits
28. Income class and pharmaceutical expenditure in Canada: 1964-1990
29. Delisting of drugs in Ontario: How attitudes and prescribing strategies of family physicians in the Kingston area changed
30. The use of first- and second-line outpatient antibiotics under the Saskatchewan drug plan
31. Do open formularies increase access to clinically useful drugs?
32. Access and cost implications of state limitations on Medicaid reimbursement for pharmaceuticals